Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin maintenance after complete remission in non-Hodgkin lymphoma
ChiCTR-OIN-17012130Phase 2Completed
- Sponsor
- Ruijin Hospital
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in non-Hodgkin lymphoma (NHL), diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Overall survival. Started Jan 2013; status: completed.
02
Drugs
metformin
03
Conditions
non-Hodgkin lymphoma (NHL)diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on ChiCTR-OIN-17012130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17012130.